| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vir Biotechnology, Inc. (VIR) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. VIR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.73M | $139.49M | - | |
| Dir | 1.10M | $11.18M | - | |
| CEO | 714.6K | $7.26M | - | |
| CFO | 160.1K | $1.63M | - | |
| VP | 104.6K | $1.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 27, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 2,930 | $30.00 | $87,900.00 | -11.0% | |
| Nov 24, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 2,340 | $27.29 | $63,848.07 | -9.0% | |
| Nov 10, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 2,340 | $26.26 | $61,448.40 | -9.0% | |
| Nov 2, 2020 | Parrish Jay | Chief Business Officer | Sale+OE | 6,944 | $31.27 | $217,152.77 | -3.0% | |
| Oct 27, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 3,805 | $35.04 | $133,334.81 | -13.8% | |
| Oct 21, 2020 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 5,000 | $31.44 | $157,209.00 | -14.4% | |
| Oct 21, 2020 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 12,500 | $35.49 | $443,608.25 | -16.2% | |
| Oct 13, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 5,560 | $43.03 | $239,236.24 | -19.0% | |
| Oct 7, 2020 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 12,500 | $41.74 | $521,795.25 | -16.2% | |
| Oct 1, 2020 | Parrish Jay | Chief Business Officer | Sale+OE | 6,945 | $34.75 | $241,341.53 | -3.0% |